Aleafia Health Inc. (ALEAF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 26, 2026

Aleafia Health Cash Flow Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '23 Mar '22 Dec '21 Dec '20 Dec '19
Net Income
-34.61-135.89-165.72-255.51-39.61
Depreciation & Amortization
6.579.6510.2810.166.43
Loss (Gain) From Sale of Assets
-0.09-9.67-12.09--0.17
Asset Writedown & Restructuring Costs
5.5874.5793.21199.59-
Loss (Gain) From Sale of Investments
1.1112.414.39-2.121.8
Stock-Based Compensation
2.42.322.832.6919.35
Provision & Write-off of Bad Debts
0.221.499.961.89-
Other Operating Activities
17.5523.2322.4133.25-7.35
Change in Accounts Receivable
1.26-3.14-4.820.11-1.59
Change in Inventory
-4.16-9.79-12.65-33.18-28.26
Change in Accounts Payable
-9.67.45.240.047.64
Change in Income Taxes
9.42-2.87--5.35
Change in Other Net Operating Assets
0.881.731.4335.458.94
Operating Cash Flow
-3.48-25.71-32.66-7.63-38.18
Capital Expenditures
-1.65-3.73-4.01-17.78-16.08
Sale of Property, Plant & Equipment
0.23----
Cash Acquisitions
----19.62
Sale (Purchase) of Real Estate
----8.71
Investment in Securities
---1.573.14
Investing Cash Flow
-1.43-3.73-4.01-16.2115.4
Long-Term Debt Issued
4.5-21.8-33.9
Total Debt Issued
4.513.1321.8-33.9
Long-Term Debt Repaid
-3.49--26.99-1.14-0.7
Total Debt Repaid
-3.49-21.6-26.99-1.14-0.7
Net Debt Issued (Repaid)
1.01-8.46-5.19-1.1433.2
Issuance of Common Stock
5.6219.3722.5615.044.42
Other Financing Activities
-2.67-4.63--0.79-
Financing Cash Flow
3.966.2717.3713.1237.62
Net Cash Flow
-0.94-23.17-19.3-10.7214.84
Free Cash Flow
-5.13-29.44-36.67-25.41-54.26
Free Cash Flow Margin
-11.98%-85.34%-101.63%-70.04%-331.84%
Free Cash Flow Per Share
-0.01-0.09-0.11-0.09-0.25
Cash Interest Paid
2.043.26---
Levered Free Cash Flow
-12.15--19.73-14.2-64.37
Unlevered Free Cash Flow
-6.3--14.63-6.92-60.65
Change in Working Capital
-2.2-3.81-7.932.42-18.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.